| Biomarkers in Patients With Advanced Rhabdomyosarcoma (NCT01668095) | Children's Oncology Group | 2012-08-01 |
| Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma (NCT01532687) | OHSU Knight Cancer Institute | 2012-03-13 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452) | National Cancer Institute (NCI) | 2010-06-01 |
| Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma (NCT01055314) | National Cancer Institute (NCI) | 2010-01-01 |
| Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00831844) | National Cancer Institute (NCI) | 2009-01-01 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174) | National Cancer Institute (NCI) | 2008-06-01 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma (NCT00354835) | Children's Oncology Group | 2006-12-26 |
| Ixabepilone in Treating Young Patients With Refractory Solid Tumors (NCT00331643) | National Cancer Institute (NCI) | 2006-04-01 |
| Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma (NCT00112463) | National Cancer Institute (NCI) | 2005-01-07 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma (NCT00003958) | Children's Oncology Group | 2002-09-01 |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma (NCT00919269) | Children's Oncology Group | 1999-03-15 |
| S9624 Ifosfamide in Treating Patients With Meningeal Tumors (NCT00003292) | SWOG Cancer Research Network | 1998-07-01 |